These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9005716)

  • 21. [Posterior laryngeal stenosis in patient with Meige's Syndrome].
    Pino Rivero V; Marcos García M; Trinidad Ruíz G; Pardo Romero G; González Palomino A; Blasco Huelva A
    An Otorrinolaringol Ibero Am; 2004; 31(4):349-54. PubMed ID: 15382486
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oromandibular dystonia questionnaire (OMDQ-25): a valid and reliable instrument for measuring health-related quality of life.
    Merz RI; Deakin J; Hawthorne MR
    Clin Otolaryngol; 2010 Oct; 35(5):390-6. PubMed ID: 21108749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meige's syndrome: History, epidemiology, clinical features, pathogenesis and treatment.
    Pandey S; Sharma S
    J Neurol Sci; 2017 Jan; 372():162-170. PubMed ID: 28017205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Meige's syndrome].
    Kimura M; Motohashi N
    Ryoikibetsu Shokogun Shirizu; 2003; (38):196-8. PubMed ID: 12876964
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of perioral dystonia with botulinum toxin in 4 cases of Meige's syndrome.
    Møller E; Werdelin LM; Bakke M; Dalager T; Prytz S; Regeur L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Nov; 96(5):544-9. PubMed ID: 14600688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced Meige's syndrome following akathisia: pharmacologic characteristics.
    Hayashi T; Furutani M; Taniyama J; Kiyasu M; Hikasa S; Horiguchi J; Yamawaki S
    Psychiatry Clin Neurosci; 1998 Aug; 52(4):445-8. PubMed ID: 9766696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe tongue protrusion dystonia: clinical syndromes and possible treatment.
    Schneider SA; Aggarwal A; Bhatt M; Dupont E; Tisch S; Limousin P; Lee P; Quinn N; Bhatia KP
    Neurology; 2006 Sep; 67(6):940-3. PubMed ID: 17000958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of blepharospasm and Meige's syndrome with abo- and onabotulinumtoxinA: long-term safety and efficacy in daily clinical practice.
    Jochim A; Meindl T; Huber C; Mantel T; Zwirner S; Castrop F; Haslinger B
    J Neurol; 2020 Jan; 267(1):267-275. PubMed ID: 31630241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lidocaine tape (Penles) reduces the pain of botulinum toxin injection for Meige syndrome.
    Onguchi T; Takano Y; Dogru M; Ono M; Tsubota K
    Am J Ophthalmol; 2004 Oct; 138(4):654-5. PubMed ID: 15488799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Meige's syndrome or segmental craniocervical dystonia: terminology, history and contemporary view].
    Zalyalova ZA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(12):133-136. PubMed ID: 26978507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term follow-up of cervical dystonia patients treated with botulinum toxin A.
    Haussermann P; Marczoch S; Klinger C; Landgrebe M; Conrad B; Ceballos-Baumann A
    Mov Disord; 2004 Mar; 19(3):303-8. PubMed ID: 15022184
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tongue protrusion dystonia: treatment with botulinum toxin.
    Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS
    South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical and demographic features of Meige's syndrome.
    Sharma AK; Behari M; Ahuja GK
    J Assoc Physicians India; 1996 Sep; 44(9):645-7. PubMed ID: 9251378
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral rehabilitation with osseointegrated implants in a patient with oromandibular dystonia with blepharospasm (Brueghel's syndrome): a patient history.
    Peñarrocha M; Sanchis JM; Rambla J; Sánchez MA
    Int J Oral Maxillofac Implants; 2001; 16(1):115-7. PubMed ID: 11280356
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inability to close eyelids as a feature of palpebral dystonia.
    Krack P; Porschke H; de Decker W; Deuschl G
    Mov Disord; 1997 Mar; 12(2):251-2. PubMed ID: 9087989
    [No Abstract]   [Full Text] [Related]  

  • 36. Development of Parkinson's disease in patients with blepharospasm.
    Micheli F; Scorticati MC; Folgar S; Gatto E
    Mov Disord; 2004 Sep; 19(9):1069-1072. PubMed ID: 15372598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024).
    Racette BA; Stambuk M; Perlmutter JS
    Mov Disord; 2002 Sep; 17(5):1098-100. PubMed ID: 12360571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-associated facial dyskinesias--a study of 238 patients.
    Mauriello JA; Carbonaro P; Dhillon S; Leone T; Franklin M
    J Neuroophthalmol; 1998 Jun; 18(2):153-7. PubMed ID: 9621275
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blepharospasm--oromandibular dystonia (Meige's syndrome) misdiagnosed as secondary hemifacial spasm.
    Gottlieb JS; May M
    Am J Otol; 1984 Jan; 5(3):206-10. PubMed ID: 6720874
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blepharospasm and oromandibular dystonia (Meige's syndrome) in sisters.
    Nutt JG; Hammerstad JP
    Ann Neurol; 1981 Feb; 9(2):189-91. PubMed ID: 7235635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.